Chimeric Antigen Receptors (CARs) are engineered receptors added to T cells to target specific proteins on cancer cells. This forms the basis of CAR T-cell therapy, a promising treatment for certain cancers.
Chimeric Antigen Receptors (CARs) are engineered receptors added to T cells to target specific proteins on cancer cells. This forms the basis of CAR T-cell therapy, a promising treatment for certain cancers.
© 2024 TFS HealthScience | Contract Research Organization | Global Resourcing Provider | CRO. All rights reserved.
Raise a ConcernPrivacy Policy and CookiesTerms and Conditions